Trump took a hair-loss drug for years. It’s no longer on his medical records.
The Washington Post
Overall Assessment
The article investigates the absence of finasteride from Trump’s medical records with a focus on transparency, medical relevance, and precedent. It balances expert opinion, historical context, and official statements without overt editorializing. The framing centers accountability rather than cosmetic concerns, elevating the story beyond appearance politics.
"Finasteride — also known by the brand name Propecia — is used by millions of American men to prevent male-pattern hair loss."
Loaded Language
Headline & Lead 90/100
The article opens with a clear, factual statement about the absence of finasteride from Trump’s current medical records, which is accurate and directly tied to the core story. The headline is straightforward and does not sensationalize.
✕ Headline / Body Mismatch: The headline focuses on a factual change in Trump's medical records regarding finasteride, which is central to the article. It avoids exaggeration and accurately reflects the reporting.
"Trump took a hair-loss drug for years. It’s no longer on his medical records."
Language & Tone 93/100
The tone is consistently professional and neutral, avoiding mockery or sensationalism despite the potentially trivial-sounding subject. Language remains clinical and objective.
✕ Loaded Language: The article uses neutral, descriptive language throughout, avoiding emotionally charged terms when describing Trump or his health.
"Finasteride — also known by the brand name Propecia — is used by millions of American men to prevent male-pattern hair loss."
✕ Loaded Language: The article reports Trump’s claims and those of his allies without endorsing or mocking them, maintaining objectivity.
"Trump’s allies have mocked the persistent focus on the president’s health, saying that many questions about his medication, appearance and aging are irrelevant to his performance."
✕ Scare Quotes: The article avoids scare quotes or ironic phrasing around Trump’s hair or appearance, treating the topic seriously.
Balance 92/100
The sourcing is robust, balanced, and diverse, featuring medical experts, former and current officials, and political allies, with clear attribution throughout.
✓ Comprehensive Sourcing: The article includes multiple expert voices from bioethics and medicine, including Klitzman, Caplan, Joffe, and Friedman, representing diverse institutions and perspectives.
"Robert Klitzman, a psychiatrist who leads Columbia University’s master’s program in bioethics, said the White House’s lack of transparency about Trump’s use of a hair-loss drug may reflect its willingness to be honest about the nearly 80-year-old president’s health."
✓ Proper Attribution: It includes past and present official sources — Bornstein, Jackson, Conley — and contrasts them with current White House silence, showing a timeline of disclosure and non-disclosure.
"Ronny Jackson, who served as Trump’s physician during a portion of his first term as president and is now a Republican congressman representing Texas, said the following year that Trump was continuing to take finasteride."
✓ Viewpoint Diversity: The article includes Trump’s own past statements and those of his allies, allowing space for the defense of privacy and irrelevance of appearance.
"Trump’s allies have mocked the persistent focus on the president’s health, saying that many questions about his medication, appearance and aging are irrelevant to his performance."
Story Angle 90/100
The story is framed as a matter of institutional transparency and public trust, not partisan politics or personal appearance, making it a serious examination of presidential accountability.
✕ Framing by Emphasis: The story is framed around transparency and accountability in presidential health disclosures, not just cosmetic treatment. This elevates the narrative beyond triviality.
"It raises significant questions of what else is possibly not being revealed"
✕ Narrative Framing: The article avoids reducing the issue to a conflict between political sides, instead focusing on systemic concerns about medical disclosure norms.
"Physicians, medical ethicists and many politicians have said that presidents should disclose health updates, particularly when it could affect their ability to govern, in an effort to build and keep public trust."
Completeness 95/100
The article thoroughly contextualizes the issue with medical, historical, and ethical dimensions, providing readers with a comprehensive understanding of why a seemingly cosmetic drug matters in presidential health reporting.
✓ Contextualisation: The article provides historical context about past presidential health disclosures, including Wilson, Kennedy, and Biden, helping readers understand the broader significance of transparency in presidential health.
"There is a long history of the White House not fully disclosing relevant medical information about the sitting president, including Woodrow Wilson’s stroke and John F. Kennedy’s significant use of painkillers."
✓ Contextualisation: The article explains the medical implications of finasteride, including its effect on PSA levels and potential mental health side effects, giving readers necessary background to assess the relevance.
"People who take finasteride report lower levels of prostate-specific antigen (PSA) in their bloodstream, a marker of potential prostate cancer."
Portrayed as lacking transparency and potentially deceptive about health disclosures
The article emphasizes a pattern of omission and lack of transparency in Trump's medical reporting, citing expert skepticism and historical concealment, which frames the presidency as untrustworthy on health matters.
"It raises significant questions of what else is possibly not being revealed"
Framed as beneficial for public trust when health information is fully disclosed
Experts are quoted advocating for full transparency, framing disclosure as essential for democratic accountability and public confidence in leadership.
"There’s a certain level of openness and disclosure that people have a right to expect from someone in whom they place such profound trust"
Framed as undermining the legitimacy of presidential health disclosures
By highlighting that Trump dictated a medical report under a physician's name and previously concealed the severity of his coronavirus infection, the article questions the credibility and legitimacy of current disclosures.
"One of Trump’s former physicians previously said that Trump dictated a medical report that was released under the physician’s name when Trump first sought the presidency more than a decade ago."
Portrayed as potentially vulnerable due to age and undisclosed health factors
The article repeatedly emphasizes Trump’s age (nearly 80), links finasteride use to potential depression, and raises concerns about cognitive fitness, framing the president’s health as a public safety concern.
"use of finasteride has been linked with an increased risk of depression, which could affect a president’s performance"
Framed as operating in a context of ongoing health-related crisis and uncertainty
The narrative structure builds urgency by listing repeated medical visits, unresolved questions about medication changes, and comparisons to past cover-ups, suggesting a presidency under health-related strain.
"Trump has visited Walter Reed National Military Medical Center three times since April 2025 amid questions about persistent bruises on his hands and swelling in his legs."
The article investigates the absence of finasteride from Trump’s medical records with a focus on transparency, medical relevance, and precedent. It balances expert opinion, historical context, and official statements without overt editorializing. The framing centers accountability rather than cosmetic concerns, elevating the story beyond appearance politics.
President Donald Trump’s recent medical reports do not include finasteride, a drug previously confirmed by his physicians to treat hair loss. Experts note its potential impact on prostate and mental health markers, while the White House states only clinically relevant medications were disclosed. Past presidents have varied in health transparency, and debate continues over what medical details should be public.
The Washington Post — Lifestyle - Health
Based on the last 60 days of articles
The Washington Post
No related content